Resources & Reports

The United States Government Accountability Office (GAO) released testimony May 19th regarding their ongoing assessment of COVID-19 flexibilities within the Medicare and Medicaid programs, as required under federal pandemic response oversight provisions included the Coronavirus Aid, Relief, and Economic Security (CARES) Act. Provided before the U.S. Senate Committee on Finance, the GAO focused its summarized findings around the effects of program flexibilities and preliminary observations related to telehealth waivers of certain federal requirements, as well as considerations regarding ongoing use.

Earlier this month Senator Mark Warner (D-VA) sent a letter to Attorney General Merrick Garland regarding the long-delayed regulations from the Drug Enforcement Agency (DEA) for a telehealth registry to prescribe controlled substances.  In the letter, Senator Warner expressed great concern for the delay and that “the DEA’s failure to address this issue means that a vast majority of health care providers that use telehealth to prescribe controlled substances to and otherwise treat their patients have been deterred in getting them the quality care they need.”

The Department of Defense (DOD) in partnership with the Council of State Governments (CSG) are helping professions to develop new interstate compacts for interstate licensure and licensure portability.